NHS England: Drugs
The question
To ask the Secretary of State for Health and Social Care, how many commercial agreements NHS England has made with manufacturers of medicines which have r resulted in indication-specific pricing between January 2020 and March 2025; and what therapeutic area these have been for.
Answered by Karin Smyth
Information provided by NHS England shows that there have been 74 commercial agreements involving indication-specific pricing arrangements between January 2020 and March 2025. The following table shows the split by therapeutic areas:
Cancer | 62 |
Haematology | 5 |
Other | 7 |
Note: therapeutic areas with fewer than five commercial agreements have been grouped under Other to avoid identification of specific commercial deals.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →